[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:atm-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"ATM Gene",25,21,[8,16,23,30,36,42,48,54,60,66,73,79,85,91,97,103,109,115,121,127,133,139,146,152,158],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05011383","High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers",[12],"Phase 2","RECRUITING","2026-08-26T02:17:47.813245Z","2026-07-24T01:27:14.925238Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07215416","Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:27.435233Z","2026-05-29T15:36:40.181904Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT05687110","Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes",[27],"Phase 1","2026-08-26T02:17:58.890423Z","2026-05-05T02:43:27.808389Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06177171","Olaparib and ASTX727 in BRCA1\u002F2- and Homologous Recombination Deficient (HRD)-Mutated Tumors",[27],"2026-08-26T02:17:22.949982Z","2026-05-05T02:43:27.676733Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT05010031","A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change",[12],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:27.279981Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05694715","Combination Therapy in Cancers With Mutations in DNA Repair Genes",[27],"2026-08-26T02:16:34.792807Z","2026-05-05T02:43:28.876459Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04657068","A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors",[20],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:28.956486Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT05013216","Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer",[27],"2026-08-26T02:16:23.080181Z","2026-05-05T02:43:26.738998Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05384535","Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort",[],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:28.342933Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":71,"content_modified":72},"NCT06122896","Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals",[70],"Early Phase 1","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:27.075591Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":52,"content_modified":78},"NCT02000089","The Cancer of the Pancreas Screening-5 CAPS5)Study",[77],"Phase 3","2026-05-05T02:43:27.641158Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT07612046","A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening",[],"2026-08-26T02:16:27.227548Z","2026-07-19T19:36:05.076756Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT03396341","Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes",[],"2026-08-26T02:16:12.203827Z","2026-07-05T05:32:16.770025Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07076147","Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer",[],"2026-08-26T02:19:06.150683Z","2026-05-13T02:55:06.650047Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06271291","Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts",[],"2026-08-26T02:18:36.226508Z","2026-05-13T02:55:06.430707Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT05058846","Pilot Study of Pancreatic Cancer Screening",[],"2026-08-03T02:54:15.542480Z","2026-05-13T02:55:06.282505Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT05006131","Pancreatic Cancer Screening for At-risk Individuals",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.277680Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT03250078","A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.120432Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT02478892","Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk",[],"2026-08-26T02:19:21.761002Z","2026-05-13T02:55:06.095979Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT04970056","Pancreatic Cancer Early Detection Consortium",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.276618Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT02775461","Pancreas Registry and High Risk Registry",[],"2026-08-26T02:15:27.567165Z","2026-05-13T02:55:06.101947Z",{"nct_id":140,"title":141,"phases":142,"status":143,"updated_at":144,"content_modified":145},"NCT07499999","Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer",[12],"NOT_YET_RECRUITING","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:29.045552Z",{"nct_id":147,"title":148,"phases":149,"status":143,"updated_at":150,"content_modified":151},"NCT07723651","[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)",[12],"2026-08-26T02:19:11.399072Z","2026-07-24T01:27:14.924205Z",{"nct_id":153,"title":154,"phases":155,"status":143,"updated_at":156,"content_modified":157},"NCT07690852","Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care",[],"2026-08-26T02:16:24.970704Z","2026-07-19T19:36:05.153122Z",{"nct_id":159,"title":160,"phases":161,"status":162,"updated_at":64,"content_modified":163},"NCT07358208","Prospective Familial Registry for Pancreas Research",[],"ENROLLING_BY_INVITATION","2026-06-16T05:54:07.881076Z"]